BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2036663)

  • 1. Guidelines for controlled trials of drugs in migraine. First edition. International Headache Society Committee on Clinical Trials in Migraine.
    Cephalalgia; 1991 Feb; 11(1):1-12. PubMed ID: 2036663
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for controlled trials of prophylactic treatment of chronic migraine in adults.
    Silberstein S; Tfelt-Hansen P; Dodick DW; Limmroth V; Lipton RB; Pascual J; Wang SJ;
    Cephalalgia; 2008 May; 28(5):484-95. PubMed ID: 18294250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for trials of behavioral treatments for recurrent headache, first edition: American Headache Society Behavioral Clinical Trials Workgroup.
    Penzien DB; Andrasik F; Freidenberg BM; Houle TT; Lake AE; Lipchik GL; Holroyd KA; Lipton RB; McCrory DC; Nash JM; Nicholson RA; Powers SW; Rains JC; Wittrock DA;
    Headache; 2005 May; 45 Suppl 2():S110-32. PubMed ID: 15921503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition.
    Diener HC; Tassorelli C; Dodick DW; Silberstein SD; Lipton RB; Ashina M; Becker WJ; Ferrari MD; Goadsby PJ; Pozo-Rosich P; Wang SJ; Mandrekar J;
    Cephalalgia; 2019 May; 39(6):687-710. PubMed ID: 30806518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guidelines for controlled trials of drugs in tension-type headache: second edition.
    Bendtsen L; Bigal ME; Cerbo R; Diener HC; Holroyd K; Lampl C; Mitsikostas DD; Steiner TJ; Tfelt-Hansen P;
    Cephalalgia; 2010 Jan; 30(1):1-16. PubMed ID: 19614696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition.
    Abu-Arafeh I; Hershey AD; Diener HC; Tassorelli C;
    Cephalalgia; 2019 Jun; 39(7):803-816. PubMed ID: 30947525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults.
    Diener HC; Tassorelli C; Dodick DW; Silberstein SD; Lipton RB; Ashina M; Becker WJ; Ferrari MD; Goadsby PJ; Pozo-Rosich P; Wang SJ; Houle TT; Hoek TCVD; Martinelli D; Terwindt GM;
    Cephalalgia; 2020 Sep; 40(10):1026-1044. PubMed ID: 32722936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic guidelines for headache].
    Nappi G; Cavallini A
    Ital J Neurol Sci; 1995 Nov; 16(8 Suppl):29-34. PubMed ID: 8751186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Controlled therapeutic trials in migraine: methodology and results].
    Baron JC; Bousser MG
    Rev Neurol (Paris); 1982; 138(4):279-95. PubMed ID: 6753081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled clinical trials of drugs for use in the prophylaxis of migraine.
    Hübbe P
    Dan Med Bull; 1975 Mar; 22(3):92-6. PubMed ID: 1093819
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drug treatment of migraine in children: state of the art].
    Cuvellier JC; Joriot S; Auvin S; Vallée L
    Arch Pediatr; 2004 May; 11(5):449-55. PubMed ID: 15135430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Musing on Mathew et al.
    Kaniecki RG
    Headache; 2003 Sep; 43(8):922; author reply 924-8. PubMed ID: 14562838
    [No Abstract]   [Full Text] [Related]  

  • 13. Drugs for migraine.
    Treat Guidel Med Lett; 2004 Sep; 2(25):63-6. PubMed ID: 15529091
    [No Abstract]   [Full Text] [Related]  

  • 14. Guidelines of the International Headache Society for controlled trials of preventive treatment of chronic migraine in adults.
    Tassorelli C; Diener HC; Dodick DW; Silberstein SD; Lipton RB; Ashina M; Becker WJ; Ferrari MD; Goadsby PJ; Pozo-Rosich P; Wang SJ;
    Cephalalgia; 2018 Apr; 38(5):815-832. PubMed ID: 29504482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics.
    Diener HC; Pfaffenrath V; Pageler L; Peil H; Aicher B; Lipton RB
    Cephalalgia; 2009 Feb; 29(2):188-93. PubMed ID: 18823361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine prophylaxis: key points for the practising clinician.
    Moschiano F; D'Amico D; Bussone G
    Neurol Sci; 2009 May; 30 Suppl 1():S33-7. PubMed ID: 19415423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Have the IHS
    Alpuente A; Tassorelli C; Diener HC; Silberstein SD; Pozo-Rosich P
    Cephalalgia; 2020 Jul; 40(8):778-787. PubMed ID: 32056459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society.
    Schulman EA; Lake AE; Goadsby PJ; Peterlin BL; Siegel SE; Markley HG; Lipton RB
    Headache; 2008 Jun; 48(6):778-82. PubMed ID: 18484982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migraine classification and diagnosis. International Headache Society criteria.
    Olesen J; Lipton RB
    Neurology; 1994 Jun; 44(6 Suppl 4):S6-10. PubMed ID: 8008227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodology of drug trials in migraine.
    Tfelt-Hansen P; Nielsen SL
    Funct Neurol; 1986; 1(4):499-502. PubMed ID: 3609877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.